You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ECOG PS

Showing 1 - 25 of 1,108
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Tianjin (Sintilimab, Bevacizumab, Liver Protective Support Therapy)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Nov 8, 2022

NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Tirelizumab；Chemotherapy monotherapy
  • (no location specified)
Jul 27, 2023

Dalpiciclib Combined With Third-generation EGFR-TKI in EGFR

Not yet recruiting
  • Non-small Cell Lung Cancer Confirmed by Histopathology or Cytology
  • +6 more
    • (no location specified)
    Aug 9, 2022

    SCLC, Extensive Stage Trial in Austria, Germany (Atezolizumab)

    Recruiting
    • SCLC, Extensive Stage
    • Klagenfurt, Austria
    • +18 more
    Apr 26, 2021

    Monitor Lung Cancer Patients Activity And Assess Performance

    Recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • Actigraphy device (wearable) and mobile application
    • Alcorcon, Madrid, Spain
    • +10 more
    Jan 13, 2023

    High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1

    Suspended
    • NSCLC Stage IV
    • NSCLC, Stage IIIC
    • Primary Immune Response (PIR) test by Biodesix, Inc.
    • San Carlos, California
    • +1 more
    Jan 26, 2023

    NSCLC (NSCLC) Trial in New York (Pembrolizumab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • New York, New York
      Mount Sinai Hospital
    Jan 23, 2023

    Biliary Tract Cancers Trial (durvalumab)

    Not yet recruiting
    • Biliary Tract Cancers
    • (no location specified)
    Jun 20, 2023

    Small Cell Lung Carcinoma Trial in France (Durvalumab)

    Recruiting
    • Small Cell Lung Carcinoma
    • Aix-en-Provence, France
    • +35 more
    Jan 16, 2023

    NSCLC Stage IV Trial in Spain (Atezolizumab)

    Completed
    • Non-small Cell Lung Cancer Stage IV
    • Elche, Alicante, Spain
    • +14 more
    Jan 26, 2023

    NSCLC (NSCLC) Trial in Worldwide (Durvalumab)

    Active, not recruiting
    Has Results
    • Non-small Cell Lung Cancer (NSCLC)
    • Gainesville, Georgia
    • +27 more
    Dec 20, 2022

    Lung Cancer Trial (Percutaneous or transbronchial argon-helium cryoablation)

    Not yet recruiting
    • Lung Cancer
    • Percutaneous or transbronchial argon-helium cryoablation
    • (no location specified)
    Apr 7, 2023

    Elderly Metastatic Colorectal Cancer Patients Trial in Padua (Capecitabine, Oxaliplatin, Bevacizumab)

    Active, not recruiting
    • Elderly Metastatic Colorectal Cancer Patients
    • Padua, Italy
      Istituto Oncologico Veneto IRCCS
    Mar 30, 2022

    Baseline Metastases on Clinical Outcomes Among BRAF Positive

    Completed
    • BRAF Positive Metastatic Melanoma
      • East Hanover, New Jersey
        Novartis
      Aug 2, 2023

      Fatigue, Locally Advanced or Metastatic Breast Cancer Trial in Germany, Italy, United States (Reparixin, Placebo)

      Recruiting
      • Fatigue
      • Locally Advanced or Metastatic Breast Cancer
      • Fort Myers, Florida
      • +23 more
      May 17, 2022

      Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor Trial in Petaling Jaya (Dendritic cell + Cytokine-induced killer cell

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Advanced Solid Tumor
      • Dendritic cell + Cytokine-induced killer cell (DC+CIK) immunotherapy
      • Tegafur Only Product
      • Petaling Jaya, Kuala Lumpur, Malaysia
        Clinical Oncology Department, Ummc
      Jul 12, 2023

      NSCLC Trial in Worldwide (Nivolumab)

      Completed
      Has Results
      • Non-Small Cell Lung Cancer
      • Wels, Oberösterreich, Austria
      • +89 more
      Oct 17, 2022

      Advanced Cancer, Metastatic Cervical Cancer Trial in Albuquerque, Yerevan (Balstilimab (BAL), Topotecan, Vinorelbine)

      Withdrawn
      • Advanced Cancer
      • Metastatic Cervical Cancer
      • Balstilimab (BAL)
      • +5 more
      • Albuquerque, New Mexico
      • +2 more
      Oct 3, 2022

      Cholangiocarcinoma Non-resectable, Cholangiocarcinoma Metastatic Trial (Ivosidenib)

      Not yet recruiting
      • Cholangiocarcinoma Non-resectable
      • Cholangiocarcinoma Metastatic
      • (no location specified)
      Oct 10, 2023

      Cholangiocarcinoma Trial in Düsseldorf (Ivosidenib Oral Tablet)

      Recruiting
      • Cholangiocarcinoma
      • Ivosidenib Oral Tablet
      • Düsseldorf, Germany
        Klinik für Gastroenterologie, Hepatologie und Infektiologie Univ
      May 17, 2023

      Nasopharyngeal Carcinoma Trial in Zhongshan (Anrotinib plus Tirelizumab)

      Recruiting
      • Nasopharyngeal Carcinoma
      • Anrotinib plus Tirelizumab
      • Zhongshan, Guangdong, China
        Zhongshan City People's Hospital
      Jul 31, 2023

      NSCLC Trial in Rochester (Pembrolizumab, Pemetrexed (Chemotherapy), Nab-paclitaxel (Chemotherapy))

      Recruiting
      • Non-small Cell Lung Cancer
      • Rochester, New York
      • +1 more
      Jan 4, 2022

      Nomogram Predicting Survival in Chinese SCLC Patients

      Completed
      • Small Cell Lung Cancer
      • initial chemotherapy response
      • (no location specified)
      Jan 8, 2023

      How Radium-223 Dichloride,Alpha Particle-emitting Radioactive

      Recruiting
      • Castration-resistant Prostate Cancer
      • Radium-223 dichloride (Xofigo, BAY88-8223)
      • Multiple Locations, Taiwan
        Many locations
      Aug 19, 2022

      Metastatic Breast Cancer Trial in Birmingham (Capecitabine Pill)

      Not yet recruiting
      • Metastatic Breast Cancer
      • Capecitabine Pill
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Oct 23, 2023